leadership
confidence high
sentiment neutral
materiality 0.90
NeuroBo Pharmaceuticals appoints Hyung Heon Kim as Chief Executive Officer and President
MetaVia Inc.
- Hyung Heon Kim appointed CEO, President, and Principal Financial Officer effective August 11, 2023, succeeding interim CEO Joseph Hooker.
- Kim previously served as General Counsel and Senior Vice President of Dong-A ST, which holds approximately 60% of NeuroBo's common stock.
- Kim received an employment agreement with a $450,000 base salary, 50% target bonus, and a restricted stock unit award of 625,064 shares.
- Joseph Hooker's departure as interim CEO was unrelated to any disagreement with the company on operations or policies.
- Board committee changes include appointments of Mark A. Glickman, Na Yeon Kim, D. Gordon Strickland, and Andrew I. Koven to various committees.